Patient Capital Management · portfolio as of Q2 2026, filed Aug 13, 2026
Latest 13F filing: Q2 2026 (filed Aug 13, 2026). No newer filing yet.
7 of 28 holdings are Undervalued or On Sale by our valuation (11% of the money).
Valued by PaybackPrice; holdings from SEC 13F filings as of Jun 30, 2026. 12 not valued.
Samantha McLemore's portfolio holds 40 stocks worth $3.1B at the end of Q2 2026. The largest positions are RPRX, C, GOOGL, UNH and AMZN.
In Q2 2026, Samantha McLemore opened 3 new positions (GPN, PPLI and GENI) and added to ADBE, BIIB, CHYM, FBTC and SOFI.
In Q2 2026, Samantha McLemore sold out of IAC, IBIT and TSLA and trimmed PLAY, DAL, GM, ILMN, OMF, NE and UBSFF.
NCLH, ADBE, JD, JPM, PLAY, APA and LEN-B are Undervalued or On Sale by our valuation.
Latest 13F filing: Q2 2026 (filed Aug 13, 2026). No newer filing yet.
From SEC Form 13F-HR — up to 45 days old at time of filing. Not a recommendation to buy or sell. Analyze any of these free →